![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Oprichter bij
NUVECTIS PHARMA, INC.
Vermogen: 18 M $ op 31-05-2026
Profiel
Dr. Enrique Poradosu is a Chief Scientific & Business Officer, Executive VP at Nuvectis Pharma, Inc. Dr. Poradosu was previously employed as a Senior VP-Business & Scientific Strategy by Stemline Therapeutics, Inc. and a Vice President-Business & Scientific Strategy by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from The Hebrew University of Jerusalem.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-04-2026 | 1.806.319 ( 6,81% ) | 18 M $ | 31-05-2026 |
Actieve functies van Enrique Poradosu
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVECTIS PHARMA, INC. | Oprichter | 27-07-2020 |
Eerdere bekende functies van Enrique Poradosu
| Bedrijven | Functie | Einde |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2020 |
| KERYX BIOPHARMACEUTICALS | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
Opleiding van Enrique Poradosu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
